Financials data is unavailable for this security.
View more
Year on year Innovative Pharmaceutical Biotech Ltd has grown net income from a loss of 245.70m to a gain of 103.40m despite declining revenues.
Gross margin | 12.74% |
---|---|
Net profit margin | 1,497.15% |
Operating margin | 4,805.16% |
Return on assets | 7.13% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in HKDView more
In 2024, Innovative Pharmaceutical Biotech Ltd increased its cash reserves by 131.03%, or 1.74m. Cash Flow from Financing totalled 10.32m or 156.54% of revenues. In addition the company used 8.28m for operations while cash from investing was breakeven.
Cash flow per share | 0.0597 |
---|---|
Price/Cash flow per share | 4.04 |
Book value per share | -0.3549 |
---|---|
Tangible book value per share | -1.15 |
More ▼
Balance sheet in HKDView more
Current ratio | 0.025 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 0.7675 |
More ▼